These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1836280)

  • 1. Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis.
    Markenson JA
    Semin Arthritis Rheum; 1991 Oct; 21(2 Suppl 1):4-12. PubMed ID: 1836280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis.
    Boonen A; Mau W
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S112-7. PubMed ID: 19822056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis.
    Carmona L; Cross M; Williams B; Lassere M; March L
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):733-45. PubMed ID: 21665122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.
    Zink A; Braun J; Listing J; Wollenhaupt J
    J Rheumatol; 2000 Mar; 27(3):613-22. PubMed ID: 10743798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinical Update and Global Economic Burden of Rheumatoid Arthritis.
    Fazal SA; Khan M; Nishi SE; Alam F; Zarin N; Bari MT; Ashraf GM
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):98-109. PubMed ID: 29141572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of rheumatoid arthritis.
    Allaire SH; Prashker MJ; Meenan RF
    Pharmacoeconomics; 1994 Dec; 6(6):513-22. PubMed ID: 10155281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and burden of illness of rheumatoid arthritis.
    Kvien TK
    Pharmacoeconomics; 2004; 22(2 Suppl 1):1-12. PubMed ID: 15157000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.
    Barrett EM; Scott DG; Wiles NJ; Symmons DP
    Rheumatology (Oxford); 2000 Dec; 39(12):1403-9. PubMed ID: 11136885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity impact of rheumatoid arthritis on society.
    McDuffie FC
    Am J Med; 1985 Jan; 78(1A):1-5. PubMed ID: 3918440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data.
    Simons WR; Rosenblatt LC; Trivedi DN
    J Occup Environ Med; 2012 Jan; 54(1):48-55. PubMed ID: 22227873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of depression among adults with rheumatoid arthritis in the United States.
    Li N; Chan E; Peterson S
    J Med Econ; 2019 Apr; 22(4):372-378. PubMed ID: 30663460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heart in rheumatoid arthritis.
    Turiel M; Sitia S; Atzeni F; Tomasoni L; Gianturco L; Giuffrida M; De Gennaro Colonna V; Sarzi-Puttini P
    Autoimmun Rev; 2010 Apr; 9(6):414-8. PubMed ID: 19913641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High work disability rate among rheumatoid arthritis patients in Lithuania.
    Dadoniene J; Stropuviene S; Venalis A; Boonen A
    Arthritis Rheum; 2004 Jun; 51(3):433-9. PubMed ID: 15188330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.
    Kiadaliri AA; Kristensen LE; Englund M
    Scand J Rheumatol; 2018 Mar; 47(2):1-101. PubMed ID: 28766390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The excess burden of rheumatoid arthritis in Ontario, Canada.
    Tarride JE; Haq M; Nakhai-Pour HR; O'Reilly DJ; Xie F; Dolovich L; Blackhouse G; Goeree R
    Clin Exp Rheumatol; 2013; 31(1):18-24. PubMed ID: 23043846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline.
    Yelin E; Wanke LA
    Arthritis Rheum; 1999 Jun; 42(6):1209-18. PubMed ID: 10366114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis.
    Kerola AM; Kauppi MJ; Nieminen T; Rantalaiho V; Kautiainen H; Kerola T; Virta LJ; Pohjolainen T; Puolakka K
    Scand J Rheumatol; 2015; 44(2):87-92. PubMed ID: 25352417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
    Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
    Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.